Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Ascorbic Acid Sterile Injection Solution

Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.

Terminated Labeling / mix-up Atlas Pharmaceuticals, LLC NDC 71591-500-50 D-0144-2020
Class II · Moderate risk

Entropic Labs SARM RAD-140

Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)

Terminated Unapproved drug Tuscano and Delucia Group (DBA Entropic Labs) D-0800-2020
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 49035-995-62 D-1869-2019
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 46122-387-23 D-1866-2019
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 60000-409-53 D-1865-2019
Class II · Moderate risk

RELPAX (eletriptan HBr)

Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.

Terminated Microbial contamination Pfizer Inc. NDC 0049-2340-45 D-1845-2019

Recalls by year